Takeda Announces FY2023 H1 Results Updates FullYear Forecasts While Remaining on Track Towards Management Guidance
Takeda TOKYO4502NYSETAK today announced financial results for the first half of fiscal year 2023 six months ended September 30 2023 updating reported and Core forecasts and reconfirming Management Guidance for Core change at CER.
United States Christopher Oreilly Christophe Weber Takeda Pharmaceutical Company Limited Growth At Constant Exchange Rate Data Technology
Source: businesswireindia.com